Kyle Mikson Analyst PerformanceManaging Director, Senior Research Analyst at Canaccord Genuity GroupKyle Mikson is a stock analyst at Canaccord Genuity Group focused in the medical sector, covering 20 publicly traded companies. Over the past year, Kyle Mikson has issued 62 stock ratings, including strong buy, buy, and hold recommendations. While full access to Kyle Mikson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kyle Mikson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings95 Last 4 YearsBuy Recommendations68.18% 60 Buy RatingsCompanies Covered20 Unique Companies Ratings Distribution88RatingsDistribution of strong buy, buy, hold, and sell ratings by Kyle Mikson.RatingPercentageCount Strong Buy1.1%1 ratings Buy67.0%59 ratings Hold31.8%28 ratings Sell0.0%0 ratingsOut of 88 total stock ratings issued by Kyle Mikson at Canaccord Genuity Group, the majority (67.0%) have been Buy recommendations, followed by 31.8% Hold and 1.1% Strong Buy.Best & Worst CallsBest Call0000.0%BDSXMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TTOOFeb 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ20 companiesKyle Mikson, an analyst at Canaccord Genuity Group, currently covers 20 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical18 companies90.0%Services1 company5.0%Computer and Technology1 company5.0%Kyle Mikson of Canaccord Genuity Group specializes in stock coverage within the Medical sector, with additional focus on Services and Computer and Technology companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE7 companies35.0%MED INSTRUMENTS3 companies15.0%MEDICAL SERVICES3 companies15.0%MED PRODUCTS2 companies10.0%MEDICAL INFO SYS2 companies10.0%SERVICES – HEALTH1 company5.0%ELEC COMP - SEMIC1 company5.0%SURGICAL & MEDICAL INSTRUMENTS1 company5.0% Kyle Mikson's Ratings History at Canaccord Genuity Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsVCYTVeracyte5/6/2026Boost Price Target$37.62$42.00Hold$0.0000.00% ROIWGSGeneDx5/5/2026Set Price Target$67.93$75.00Buy$0.0000.00% ROIBDSXBiodesix5/5/2026Boost Price Target$14.78$22.00Buy$0.0000.00% ROISEERSeer5/4/2026Initiated Coverage$2.03$4.00Buy$0.0000.00% ROISEERSeer5/4/2026Upgrade$1.86$4.00Strong-Buy$0.0000.00% ROIILMNIllumina5/1/2026Lower Price Target$126.74$140.00Hold$0.0000.00% ROIXGNExagen4/20/2026Lower Price Target$2.96$8.00Buy$0.0000.00% ROIWGSGeneDx4/20/2026Set Price Target$68.51$100.00Buy$0.0000.00% ROIRGENRepligen4/20/2026Lower Price Target$132.53$145.00Hold$0.0000.00% ROIQTRXQuanterix4/20/2026Lower Price Target$3.43$4.00Hold$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CSTLCastle Biosciences4/20/2026Lower Price Target$25.21$40.00Buy$0.0000.00% ROIVCYTVeracyte4/20/2026Lower Price Target$33.40$40.00Hold$0.0000.00% ROITXG10x Genomics4/20/2026Boost Price Target$25.25$32.00Buy$0.0000.00% ROICAICaris Life Sciences3/13/2026Lower Price Target$18.10$22.00Hold$0.0000.00% ROIXGNExagen3/11/2026Lower Price Target$3.08$10.00Buy$0.0000.00% ROIQSIQuantum-Si3/4/2026Lower Price Target$0.93$1.00Hold$0.0000.00% ROIGRALGRAIL2/20/2026Lower Price Target$101.53$80.00Buy$0.0000.00% ROIGHGuardant Health2/20/2026Boost Price Target$106.38$135.00Buy$0.0000.00% ROIBDSXBiodesix2/17/2026Reiterated Rating$11.11$20.00Buy$0.0000.00% ROITXG10x Genomics2/13/2026Set Price Target$17.51$22.00$0.0000.00% ROIILMNIllumina1/26/2026Boost Price Target$150.28$150.00Hold$0.0000.00% ROINTRANatera1/12/2026Reiterated Rating$234.31Buy$0.0000.00% ROICAICaris Life Sciences12/22/2025Boost Price Target$27.94$30.00Hold$0.0000.00% ROITXG10x Genomics12/22/2025Boost Price Target$16.05$20.00Buy$0.0000.00% ROITEMTempus AI12/22/2025Lower Price Target$64.46$80.00Buy$0.0000.00% ROIQTRXQuanterix12/22/2025Boost Price Target$6.59$8.00Hold$0.0000.00% ROIQSIQuantum-Si12/22/2025Lower Price Target$1.27$1.50Hold$0.0000.00% ROINTRANatera12/22/2025Boost Price Target$231.96$285.00Buy$0.0000.00% ROIILMNIllumina12/22/2025Boost Price Target$134.78$130.00Hold$0.0000.00% ROIGHGuardant Health12/22/2025Boost Price Target$99.74$125.00Buy$0.0000.00% ROICSTLCastle Biosciences12/22/2025Boost Price Target$39.44$50.00Buy$0.0000.00% ROIWGSGeneDx12/22/2025Boost Price Target$140.44$170.00Buy$0.0000.00% ROINTRANatera12/8/2025Reiterated Rating$241.17$250.00Buy$0.0000.00% ROICAICaris Life Sciences12/2/2025Initiated Coverage$28.86$28.00Hold$0.0000.00% ROIEXASExact Sciences11/25/2025Downgrade$101.01$105.00Hold$0.0000.00% ROIGRALGRAIL11/17/2025Boost Price Target$79.63$105.00Buy$0.0000.00% ROINTRANatera11/7/2025Boost Price Target$199.57$250.00Buy$0.0000.00% ROITXG10x Genomics11/7/2025Boost Price Target$15.25$19.00Buy$0.0000.00% ROIVCYTVeracyte11/5/2025Boost Price Target$36.12$43.00Hold$0.0000.00% ROITEMTempus AI11/5/2025Lower Price Target$84.49$95.00Buy$0.0000.00% ROI$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.Watch the free video to get the ticker today.ILMNIllumina10/31/2025Boost Price Target$99.01$112.00Hold$0.0000.00% ROIGHGuardant Health10/30/2025Set Price Target$72.27$100.00$0.0000.00% ROIGHGuardant Health10/30/2025Boost Price Target$72.27$100.00Buy$0.0000.00% ROIWGSGeneDx10/29/2025Set Price Target$140.19$160.00Buy$0.0000.00% ROIRGENRepligen10/29/2025Boost Price Target$152.85$165.00Hold$0.0000.00% ROIXGNExagen10/27/2025Boost Price Target$11.96$15.00Buy$0.0000.00% ROIQSIQuantum-Si10/27/2025Boost Price Target$2.29$2.00Hold$0.0000.00% ROIGRALGRAIL10/22/2025Boost Price Target$81.33$85.00Buy$0.0000.00% ROIWGSGeneDx10/20/2025Set Price Target$120.94$155.00Buy$0.0000.00% ROIVCYTVeracyte10/20/2025Initiated Coverage$35.83$40.00Hold$0.0000.00% ROITEMTempus AI10/20/2025Initiated Coverage$87.78$110.00Buy$0.0000.00% ROINTRANatera10/14/2025Reiterated Rating$172.81$200.00Buy$0.0000.00% ROIGRALGRAIL10/3/2025Boost Price Target$72.37$75.00Buy$0.0000.00% ROIGHGuardant Health9/26/2025Boost Price Target$60.18$75.00Buy$0.0000.00% ROIBDSXBiodesix9/19/2025Set Price Target$6.77$20.00Buy$0.0000.00% ROIQSIQuantum-Si9/9/2025Reiterated Rating$1.08$1.00Hold$0.0000.00% ROICSTLCastle Biosciences9/9/2025Reiterated Rating$24.05$37.00Buy$0.0000.00% ROITXG10x Genomics8/11/2025Set Price Target$12.41$16.00$0.0000.00% ROIQTRXQuanterix8/11/2025Reiterated Rating$4.75$5.00Hold$0.0000.00% ROIILMNIllumina8/1/2025Boost Price Target$96.17$105.00Hold$0.0000.00% ROIXGNExagen7/30/2025Boost Price Target$8.45$11.00Buy$0.0000.00% ROIILMNIllumina6/11/2025Boost Price Target$87.98$99.00Hold$0.0000.00% ROIBDSXBiodesix5/14/2025Lower Price Target$4.40$30.00Buy$00.0000.00% ROIXGNExagen5/13/2025Boost Price Target$5.48$8.00Buy$0.0000.00% ROIQTRXQuanterix5/13/2025Lower Price Target$4.75$12.00Buy$0.0000.00% ROIILMNIllumina5/12/2025Lower Price Target$75.76$87.00Hold$000.0000.00% ROITXG10x Genomics5/12/2025Lower Price Target$9.44$15.00Buy$00.0000.00% ROICSTLCastle Biosciences5/6/2025Lower Price Target$18.75$37.00Buy$00.0000.00% ROIGHGuardant Health5/1/2025Boost Price Target$48.89$65.00Buy$00.0000.00% ROIILMNIllumina4/29/2025Lower Price Target$77.22$92.00Hold$000.0000.00% ROIBDSXBiodesix4/29/2025Lower Price Target$11.40$50.00Buy$0.0000.00% ROIGRALGRAIL4/21/2025Initiated Coverage$27.00$32.00Buy$00.0000.00% ROIPACBPacific Biosciences of California4/10/2025Reiterated Rating$1.38$3.00Buy$0.0000.00% ROIQTRXQuanterix3/18/2025Lower Price Target$7.28$15.00Buy$0.0000.00% ROIILMNIllumina3/11/2025Lower Price Target$85.97$115.00Hold$000.0000.00% ROINTRANatera2/26/2025Reiterated Rating$161.43$180.00Buy$000.0000.00% ROIGHGuardant Health2/24/2025Boost Price Target$42.87$60.00Buy$00.0000.00% ROITXG10x Genomics2/13/2025Lower Price Target$11.94$18.00Buy$00.0000.00% ROIILMNIllumina2/7/2025Lower Price Target$112.34$135.00Hold$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
